Submitted by Anonymous (not verified) on 6 August 2026 - 16:16
Human medicines European public assessment report (EPAR): Breyanzi, lisocabtagene maraleucel, Date of authorisation: 04/04/2022, Revision: 12, Status: Authorised
Source:
Human medicines European public assessment report (EPAR): Breyanzi, lisocabtagene maraleucel, Date of authorisation: 04/04/2022, Revision: 12, Status: Authorised